Jia Qi, Jiang Fan, Ma Daliang, Li Jun, Wang Fan, Wang Zhiqiang
Encephalopathy Center, The Third People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830000, People's Republic of China.
Neonatal Intensive Care Unit, The First People's Hospital of Urumqi, Urumqi 830000, People's Republic of China.
Neuropsychiatr Dis Treat. 2020 Aug 11;16:1955-1963. doi: 10.2147/NDT.S257870. eCollection 2020.
To study the association between IL-6 level and seizure recurrence in patients with the first post-ischemic stroke seizure and assess its predictive value for seizure recurrence.
A total of 2976 consecutive ischemic stroke patients were retrospectively enrolled. Among them, 209 (7.02%) patients with the first post-ischemic stroke seizure were included in this analysis. The IL-6 mRNA expression level was evaluated through quantitative real-time PCR (qRT-PCR) and the 2 method. Demographic data and clinical characteristics were collected. Univariate analysis was performed with independent-samples -test, Mann-Whitney -test, or chi-square test. Multivariate analysis was conducted using a backward stepwise logistic regression model for variables with <0.10 in univariate analysis. The predictive value was assessed using a receiver operating characteristic (ROC) curve.
Among the patients included, 105 (50.24%) had recurrence of seizures, and 104 (49.76%) had no recurrence. Multivariate analysis demonstrated that the IL-6 mRNA expression level was independently correlated with seizure recurrence in patients with the first post-ischemic stroke seizure after adjusting for age, NIHSS scores, time of seizure, seizure type, lesion size, location of the offending lesion to different hemispheric lobes, cortical involvement, gender, electroencephalography (EEG) findings, and hemorrhagic transformation. When the IL-6 mRNA expression level was used to predict seizure recurrence, the area under the ROC curve (AUC) was 0.763 (SE=0.033, 95% CI=0.698-0.829). The diagnostic power was moderate.
IL-6 was independently correlated with seizure recurrence in patients with the first post-ischemic stroke seizure and might be a potential biomarker for prediction of seizure recurrence.
研究首次缺血性卒中后癫痫发作患者白细胞介素-6(IL-6)水平与癫痫复发之间的关联,并评估其对癫痫复发的预测价值。
回顾性纳入2976例连续的缺血性卒中患者。其中,209例(7.02%)首次缺血性卒中后癫痫发作的患者纳入本分析。通过定量实时聚合酶链反应(qRT-PCR)和2−ΔΔCt法评估IL-6信使核糖核酸(mRNA)表达水平。收集人口统计学数据和临床特征。采用独立样本t检验、曼-惠特尼U检验或卡方检验进行单因素分析。对单因素分析中P<0.10的变量,使用向后逐步逻辑回归模型进行多因素分析。使用受试者工作特征(ROC)曲线评估预测价值。
纳入的患者中,105例(50.24%)癫痫复发,104例(49.76%)未复发。多因素分析表明,在校正年龄、美国国立卫生研究院卒中量表(NIHSS)评分、癫痫发作时间、癫痫发作类型、病灶大小、责任病灶位于不同脑叶的位置、皮质受累情况、性别、脑电图(EEG)结果和出血性转化后,IL-6 mRNA表达水平与首次缺血性卒中后癫痫发作患者的癫痫复发独立相关。当用IL-6 mRNA表达水平预测癫痫复发时,ROC曲线下面积(AUC)为0.763(标准误=0.033,95%可信区间=0.698−0.829)。诊断效能中等。
IL-6与首次缺血性卒中后癫痫发作患者的癫痫复发独立相关,可能是预测癫痫复发的潜在生物标志物。